Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-30

Clinical Trial Update: Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

View source ↗

Summary

This completed clinical trial assessed EyeArt, an automated screening tool for diabetic retinopathy, as a screening modality for diabetic eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EyeArt

Snippet

Sponsor: Eyenuk, Inc. | Conditions: Diabetic Retinopathy, Diabetic Eye Problems | Status: COMPLETED